Opportunity Information: Apply for PA 09 101
Apply for PA 09 101
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Energy Efficiency and Renewable Energy System Technology Research and Development (STTR R41/R42)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121 Oral Diseases and Disorders Research 93.273 Alcohol Research Programs 93.279 Drug Abuse and Addiction Research Programs 93.389 National Center for Research Resources 93.839 Blood Diseases and Resources Research 93.855 Allergy, Immunology and Transplantation Research 93.856 Microbiology and Infectious Diseases Research 93.859 Biomedical Research and Research Training 93.866 Aging Research.
- This funding opportunity was created on Feb 12, 2009 and posted on Feb 12, 2009.
- Applicants must submit their applications by Jan 7, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Energy Efficiency and Renewable Energy System Technology Research and Development opportunity (STTR R41/R42), Funding Opportunity Number PA-09-101, is a National Institutes of Health (NIH) discretionary grant announcement designed to steer small business biomedical innovation toward energy-related goals set by federal law. It was issued in response to the Energy Independence and Security Act of 2007 (Public Law 110-140), signed on December 19, 2007, which directs federal agencies that run SBIR and STTR programs to give high priority, whenever feasible and appropriate, to research and development projects that advance energy efficiency or renewable energy systems. In practical terms, NIH is signaling that it wants U.S. small businesses working in biomedical areas to consider how their technologies, processes, devices, instrumentation, or research tools could meaningfully contribute to reducing energy use, improving energy efficiency, or enabling renewable energy system development, and to propose R and D projects aligned with those outcomes.
This announcement specifically uses the Small Business Technology Transfer (STTR) mechanisms, meaning applicants apply through the R41 (Phase I) and R42 (Phase II) pathways, with an option to submit Fast Track applications that combine Phase I and Phase II in a coordinated plan. STTR is structured around collaboration, so the core concept is a partnership between an eligible U.S. small business concern and a nonprofit research institution, with the work shared between the two in a way that supports technology translation and commercialization. NIH positioned this FOA to run in parallel with a companion announcement of the same scientific scope that uses the SBIR mechanisms instead (PA-09-100, R43/R44), giving small businesses two closely related routes depending on whether the project is better suited to SBIR or to the STTR collaboration model.
Eligibility is limited to small businesses, and the funding instrument is a grant. The funding activity categories are listed under education and health, and the announcement is tied to multiple CFDA program areas across NIH, including oral diseases and disorders, alcohol research, drug abuse and addiction, the National Center for Research Resources, blood diseases and resources, allergy/immunology/transplantation, microbiology and infectious diseases, biomedical research and research training, and aging research. This wide range of CFDA linkages reflects NIHs broad biomedical mission and indicates that projects could be relevant to many NIH Institutes and Centers, as long as the proposed biomedical research and development also connects in a credible, research-driven way to energy efficiency or renewable energy system technology goals.
The announcement does not require cost sharing or matching, which lowers barriers for small businesses that may not have substantial non-federal capital available at the early R and D stage. At the same time, the FOA makes clear that awards are contingent on the availability of funds and on the submission of a sufficient number of strong applications. NIH does not guarantee a set number of awards or a fixed total amount under this FOA; instead, the size and number of awards depend on the quality of proposals, the project periods, and the budgets requested by applicants. In other words, funding decisions are competitive and merit-based, and the agency retains flexibility to support the most compelling projects that fit the purpose of the announcement.
Key timeline details in the source data show the FOA was posted and created on February 12, 2009, with an original closing date of January 7, 2012, and an archive date of February 7, 2012. The official NIH guide link is provided in the record (http://grants.nih.gov/grants/guide/pa-files/PA-09-101.html), and NIH points applicants to the NIH Office of Extramural Research (OER) webmaster contacts for access or linking issues. Overall, PA-09-101 is best understood as an NIH STTR funding pathway aimed at small businesses developing biomedical technologies that also deliver measurable contributions to national priorities in energy efficiency and renewable energy systems, using the phased R41/R42 structure to support early feasibility work through more advanced development and commercialization-oriented R and D.
Frequently Asked Questions (FAQs)
What is the name of this funding opportunity?
The opportunity is titled "Energy Efficiency and Renewable Energy System Technology Research and Development" and it is offered under the STTR R41/R42 mechanisms.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is PA-09-101.
Which federal agency is offering this opportunity?
This is a National Institutes of Health (NIH) discretionary grant announcement.
What is the main purpose of PA-09-101?
The purpose is to encourage U.S. small businesses working on biomedical innovation to propose research and development projects that also advance energy efficiency or renewable energy system technology goals, such as reducing energy use, improving energy efficiency, or enabling renewable energy system development.
What law or policy is this opportunity responding to?
PA-09-101 was issued in response to the Energy Independence and Security Act of 2007 (Public Law 110-140), signed on December 19, 2007, which directs agencies running SBIR/STTR programs to give high priority (when feasible and appropriate) to R&D that advances energy efficiency or renewable energy systems.
What funding mechanism does this announcement use?
This announcement uses the Small Business Technology Transfer (STTR) mechanisms, specifically R41 (Phase I) and R42 (Phase II).
What is the difference between Phase I (R41) and Phase II (R42) in this announcement?
Based on the announcement description, R41 supports early-stage feasibility work (Phase I), and R42 supports more advanced development activities (Phase II) with a focus aligned to technology translation and commercialization-oriented R&D.
Does this FOA allow Fast Track applications?
Yes. The announcement notes an option to submit Fast Track applications that combine Phase I and Phase II into a coordinated plan.
Who is eligible to apply?
Eligibility is limited to small businesses in the United States, using the STTR structure described in the opportunity.
Is a research institution partner required?
Yes. STTR is structured around collaboration, and the core concept described here is a partnership between an eligible U.S. small business concern and a nonprofit research institution, with the work shared between them to support technology translation and commercialization.
What kinds of projects are NIH looking for under this opportunity?
NIH is signaling interest in biomedical technologies, processes, devices, instrumentation, or research tools where the proposed R&D can credibly contribute to energy-related outcomes, such as reducing energy use, improving energy efficiency, or enabling renewable energy system technology development.
Does the project have to be biomedical?
Yes. The announcement is an NIH biomedical innovation opportunity, and the description indicates projects should be relevant to NIH's broad biomedical mission while also connecting in a credible, research-driven way to energy efficiency or renewable energy system technology goals.
What topic areas across NIH could this relate to?
The record links the announcement to multiple CFDA program areas across NIH, including oral diseases and disorders; alcohol research; drug abuse and addiction; the National Center for Research Resources; blood diseases and resources; allergy/immunology/transplantation; microbiology and infectious diseases; biomedical research and research training; and aging research.
How broad is the scientific scope?
The CFDA linkages described indicate a wide biomedical scope across NIH Institutes and Centers, as long as the application aligns biomedical R&D with energy efficiency or renewable energy system technology outcomes.
Is this an SBIR or an STTR opportunity?
This specific announcement (PA-09-101) is STTR (R41/R42). The description also notes a companion NIH announcement with the same scientific scope that uses SBIR mechanisms (PA-09-100, R43/R44).
What is the companion announcement and how is it related?
The companion announcement is PA-09-100 (R43/R44), which uses SBIR mechanisms and is described as having the same scientific scope. The two routes are presented as options depending on whether a project is better suited to SBIR or the STTR collaboration model.
What type of funding instrument is used?
The funding instrument is a grant.
Are cost sharing or matching funds required?
No. The announcement explicitly states that cost sharing or matching is not required.
Does NIH guarantee a certain number of awards or a fixed total funding amount?
No. The description states awards are contingent on availability of funds and on receiving a sufficient number of strong applications. NIH does not guarantee a set number of awards or a fixed total amount; the number and size of awards depend on proposal quality, project periods, and requested budgets.
How are funding decisions made under this FOA?
Funding decisions are competitive and merit-based, and NIH retains flexibility to support the most compelling projects that fit the purpose of the announcement, subject to funds availability and the strength of the application pool.
When was PA-09-101 posted and created?
The source data states the FOA was posted and created on February 12, 2009.
What was the closing date for this opportunity?
The original closing date listed is January 7, 2012.
When was this opportunity archived?
The archive date listed is February 7, 2012.
Where can applicants find the official NIH guide posting for PA-09-101?
The official NIH guide link provided is http://grants.nih.gov/grants/guide/pa-files/PA-09-101.html.
Who is listed as a contact for access or linking issues?
NIH points applicants to the NIH Office of Extramural Research (OER) webmaster contacts for access or linking issues.
How should an applicant think about aligning a biomedical project with the energy focus described?
Based on the description, the project should make a meaningful, research-driven case that the biomedical technology or tool being developed will reduce energy use, improve energy efficiency, or enable renewable energy system technology development, while remaining within NIH-relevant biomedical R&D.
What are the listed funding activity categories?
The funding activity categories are listed under education and health.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Energy Efficiency and Renewable Energy System Technology Research and Development (SBIR R43/R44)
Previous opportunity: Global Food Security Response Africa Action Plan
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 09 101
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 09 101) also looked into and applied for these:
| Funding Opportunity |
|---|
| Energy Efficiency and Renewable Energy System Technology Research and Development (SBIR R43/R44) Apply for PA 09 100 Funding Number: PA 09 100 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol and Nicotine Co Dependence (R21) Apply for PA 09 098 Funding Number: PA 09 098 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Mechanisms of Alcohol and Nicotine Co Dependence (R01) Apply for PA 09 099 Funding Number: PA 09 099 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Manufacturing Processes of Medical, Dental, and Biological Technologies (SBIR R43/R44) Apply for PA 09 113 Funding Number: PA 09 113 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Manufacturing Processes of Medical, Dental, and Biological Technologies (STTR R41/R42) Apply for PA 09 114 Funding Number: PA 09 114 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Pregnant/Postpartum Women with Substance Related Disorders and/or In Utero Substance Exposed Neonates (R01) Apply for PA 09 106 Funding Number: PA 09 106 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Pregnant/Postpartum Women with Substance Related Disorders and/or In Utero Substance Exposed Neonates (R21) Apply for PA 09 107 Funding Number: PA 09 107 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| The Integrative Cancer Biology Program (ICBP) Centers for Cancer Systems Biology (CCSB) (U54) Apply for RFA CA 09 011 Funding Number: RFA CA 09 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Clinical Research Curriculum Award (K30) Apply for RFA RR 09 006 Funding Number: RFA RR 09 006 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Research on Clinical Decision Making in People with or at Risk for Life Threatening Illness (R01) Apply for PA 09 122 Funding Number: PA 09 122 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biobehavioral Methods to Improve Outcomes Research (R21) Apply for PA 09 126 Funding Number: PA 09 126 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Exploratory Grants for Behavioral Research in Cancer Control (R21) Apply for PA 09 130 Funding Number: PA 09 130 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Interventions to Improve Palliative Care at the End of Life (R01) Apply for RFA NR 09 004 Funding Number: RFA NR 09 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Incorporating Cost Effectiveness Analysis Into Factors Affecting Quality of Life Health Related Research (R01) Apply for RFA NR 09 005 Funding Number: RFA NR 09 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Research on Clinical Decision Making in People with or at Risk for Life Threatening Illness (R21) Apply for PA 09 121 Funding Number: PA 09 121 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Biomedical Research on the International Space Station (BioMed ISS) (UH2/UH3) Apply for PAR 09 120 Funding Number: PAR 09 120 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Building System Capacity for Implementing Evidence Based Practices in Substance Abuse Treatment and Prevention (R34) Apply for PA 09 105 Funding Number: PA 09 105 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Surveillance Using Health Claims based Data System (R03) Apply for PA 09 143 Funding Number: PA 09 143 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Surveillance Using Health Claims based Data System (R21) Apply for PA 09 144 Funding Number: PA 09 144 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Cancer Surveillance Using Health Claims based Data System (R01) Apply for PA 09 145 Funding Number: PA 09 145 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 09 101", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.